DEA and HHS Extend COVID-19 Telemedicine Flexibilities for Controlled Medication Prescriptions

Summary

The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have extended temporary exceptions for prescribing controlled medications via telemedicine until November 11, 2023, as part of their ongoing efforts to address the COVID-19 pandemic and ensure continued access to care.